APA

Riedl M. A., Bernstein J. A., Li H., Reshef A., Lumry W., Moldovan D., Farkas H., Levy R., Baker J., Hardiman Y., Totoritis M. C., Relan A. & Cicardi M. (20140326). Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Chicago

Riedl Marc A, Bernstein Jonathan A, Li Henry, Reshef Avner, Lumry William, Moldovan Dumitru, Farkas Henriette, Levy Robyn, Baker James, Hardiman Yun, Totoritis Mark C, Relan Anurag and Cicardi Marco. 20140326. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Harvard

Riedl M. A., Bernstein J. A., Li H., Reshef A., Lumry W., Moldovan D., Farkas H., Levy R., Baker J., Hardiman Y., Totoritis M. C., Relan A. and Cicardi M. (20140326). Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

MLA

Riedl Marc A, Bernstein Jonathan A, Li Henry, Reshef Avner, Lumry William, Moldovan Dumitru, Farkas Henriette, Levy Robyn, Baker James, Hardiman Yun, Totoritis Mark C, Relan Anurag and Cicardi Marco. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 20140326.